|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 306.15 EUR | -0.05% |
|
+1.97% | +9.22% |
| 15/06 | Mizuho Securities Lifts Price Target on Amgen to $303 From $295, Keeps Outperform Rating | MT |
| 15/06 | Global drugmakers invest billions to boost US presence | RE |
| Market Cap | 19TCr 16TCr 15TCr 14TCr 26TCr 17,87900Cr 27TCr 1,77400Cr 69TCr 8,75600Cr 71TCr 69TCr 30,29700Cr | P/E Ratio 2026 * |
22.8x | P/E Ratio 2027 * | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 23TCr 20TCr 18TCr 17TCr 32TCr 21,77600Cr 33TCr 2,16100Cr 84TCr 10,66400Cr 86TCr 85TCr 36,90100Cr | EV / Sales 2026 * |
6.1x | EV / Sales 2027 * | 5.79x |
| Free-Float |
99.78% | Yield 2026 * |
2.88% | Yield 2027 * | 3.04% |
Last Transcript: Amgen Inc.
| 1 day | -0.05% | ||
| 1 week | +1.97% | ||
| Current month | +6.86% | ||
| 1 month | +8.66% | ||
| 3 months | -4.66% | ||
| 6 months | +12.37% | ||
| Current year | +9.22% |
| 1 week | 292.05 |  | 309.4 |
| 1 month | 276.45 | | 309.4 |
| Current year | 271.8 | | 333 |
| 1 year | 230 | | 333 |
| 3 years | 199.8 | | 333 |
| 5 years | 174.58 | | 333 |
| 10 years | 120.65 | | 333 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 01/01/2020 |
Esteban Santos
COO | Chief Operating Officer | 59 | 25/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.05% | +1.97% | - | - | 19TCr | |
| -0.32% | -1.72% | +37.83% | +148.79% | 1,01000Cr | |
| -2.16% | +1.51% | +50.01% | +43.93% | 58TCr | |
| -2.70% | -0.66% | +15.97% | +63.07% | 40TCr | |
| -1.18% | +1.05% | +20.91% | +18.37% | 33TCr | |
| -1.52% | +2.45% | +23.73% | +33.03% | 28TCr | |
| -1.95% | -4.32% | +20.15% | +12.96% | 28TCr | |
| -0.57% | +5.00% | -44.67% | -48.28% | 20TCr | |
| -0.38% | -2.97% | +13.02% | +57.34% | 16TCr | |
| -0.80% | +1.48% | +5.95% | -34.59% | 15TCr | |
| Average | -1.16% | +0.03% | +15.88% | +32.74% | 37.63TCr | |
| Weighted average by Cap. | -0.99% | -0.18% | +25.68% | +63.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.78TCr 3.26TCr 3TCr 2.81TCr 5.28TCr 3,57200Cr 5.34TCr 35TCr 14TCr 1,74900Cr 14TCr 14TCr 6,05300Cr | 3.88TCr 3.34TCr 3.07TCr 2.88TCr 5.42TCr 3,66200Cr 5.47TCr 36TCr 14TCr 1,79400Cr 15TCr 14TCr 6,20600Cr |
| Net income | 826.46Cr 712.33Cr 655.58Cr 615.01Cr 1.16TCr 78TCr 1.17TCr 7.75TCr 3.03TCr 38TCr 3.1TCr 3.04TCr 1,32400Cr | 904.06Cr 779.21Cr 717.13Cr 672.75Cr 1.26TCr 85TCr 1.28TCr 8.48TCr 3.31TCr 42TCr 3.39TCr 3.32TCr 1,44800Cr |
| Net Debt | 4.12TCr 3.55TCr 3.27TCr 3.07TCr 5.76TCr 3,89700Cr 5.82TCr 39TCr 15TCr 1,90800Cr 15TCr 15TCr 6,60300Cr | 3.51TCr 3.02TCr 2.78TCr 2.61TCr 4.9TCr 3,31600Cr 4.95TCr 33TCr 13TCr 1,62400Cr 13TCr 13TCr 5,61800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 306.15 € | -0.05% | 297 |
| 12/26/12 | 306.30 € | +0.92% | 280 |
| 11/26/11 | 303.50 € | +1.02% | 489 |
| 10/26/10 | 300.45 € | +0.40% | 598 |
| 09/26/09 | 299.25 € | -0.33% | 128 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
Select your edition
All financial news and data tailored to specific country editions
